Sarepta’s gene therapy vector wins FDA platform technology statusnews2025-06-04T19:49:13+00:00June 4th, 2025|Endpoints News|
#ASCO25: Brain cancer cell therapies make early stridesnews2025-06-03T10:00:45+00:00June 3rd, 2025|Endpoints News|
#ASCO25: Immatics reports more early-stage data for melanoma cell therapy with pivotal trial underwaynews2025-05-31T12:00:59+00:00May 31st, 2025|Endpoints News|
Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDAnews2025-05-27T11:24:26+00:00May 27th, 2025|Endpoints News|
CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answernews2025-05-20T18:52:16+00:00May 20th, 2025|Endpoints News|
Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in fundsnews2025-05-20T04:01:33+00:00May 20th, 2025|Endpoints News|
Prime Medicine sidelines only clinical program, replaces CEO and lays off some staffnews2025-05-19T15:33:27+00:00May 19th, 2025|Endpoints News|
Intellia’s CRISPR therapy likely causes ‘permanent’ gene knockdown in ATTR amyloidosisnews2025-05-19T15:14:34+00:00May 19th, 2025|Endpoints News|
David Liu, Sam Sternberg unveil new way to insert big genes in human cellsnews2025-05-19T14:31:07+00:00May 19th, 2025|Endpoints News|
#ASGCT25: Lower conference attendance mirrors challenged cell and gene fieldnews2025-05-16T16:33:44+00:00May 16th, 2025|Endpoints News|
